SLP:NASDAQSimulations Plus, Inc. Analysis

Simulations Plus delivered an 8% year‑over‑year revenue increase, driven by solid software sales and a rebound in services, while maintaining a strong gross margin of 62% and an operating margin of 23%. However, the company still posted a negative profit margin of -78% and a trailing EPS of -3.12, reflecting ongoing profitability challenges despite robust cash of $41.8 M and minimal debt. The stock trades at $14.17, well below the DCF‑derived fair value of $18.13, implying an upside potential of roughly 67% and placing it in the undervalued category. Technicals show a neutral price trend with the 20‑day SMA at 13.88, a bearish MACD histogram, and a decreasing volume trend, while the RSI sits at a moderate 55, suggesting limited short‑term momentum.
The broader market sentiment is extremely bullish, as indicated by a Fear & Greed Index of 90.9 (Extreme Greed), but the stock’s high 30‑day volatility of 48% and beta of 1.24 highlight elevated market risk. With a supportive cash position, low leverage (debt‑to‑equity 0.38), and forward EPS turning positive, the longer‑term outlook is anchored in the growing demand for AI‑driven drug development tools, positioning SLP as a potential growth‑value blend opportunity.